Try our Advanced Search for more refined results

Merck Can't Escape Fosamax MDL, Patients Tell High Court

By Rachel Graf (October 27, 2017, 8:39 PM EDT) -- Patients suing Merck Sharp & Dohme Corp. over its alleged failure to warn about potential femoral fractures from its osteoporosis drug Fosamax have urged the Supreme Court to keep the multidistrict litigation alive, saying the Third Circuit properly determined the U.S. Food and Drug Administration took issue with the words "stress fracture."...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!